51
|
Steinberg A, Callaway C, Dezfulian C, Elmer J. Are providers overconfident in predicting outcome after cardiac arrest? Resuscitation 2020; 153:97-104. [PMID: 32544415 DOI: 10.1016/j.resuscitation.2020.06.004] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2020] [Revised: 05/24/2020] [Accepted: 06/04/2020] [Indexed: 01/28/2023]
Abstract
AIM To quantify the accuracy of health care providers' predictions of survival and function at hospital discharge in a prospective cohort of patients resuscitated from cardiac arrest. To test whether self-reported confidence in their predictions was associated with increased accuracy and whether this relationship varied across providers. METHODOLOGY We presented critical care and neurology providers with clinical vignettes using real data from post-arrest patients. We asked providers to predict survival, function at discharge, and report their confidence in these predictions. We used mixed effects models to explore predictors of confidence, accuracy, and the relationship between the two. RESULTS We completed 470 assessments of 62 patients with 65 providers. Of patients, 49 (78%) died and 9 (15%) had functionally favourable survival. Providers accurately predicted survival in 308/470 (66%) assessments. In most errors (146/162, 90%), providers incorrectly predicted survival. Providers accurately predicted function in 349/470 (74%) assessments. In most errors (114/121, 94%), providers incorrectly predicted favourable functional recovery. Providers were confident (median confidence predicting survival 80 [IQR 60-90]; median confidence predicting function 80 [IQR 60-95]). Confidence explained 9% and 18% of variation in accuracy predicting survival and function, respectively. We observed significant between-provider variability in accuracy (median odds ratio (MOR) for predicting survival 2.93, 95%CI 1.94-5.52; MOR for predicting function 5.42, 95%CI 3.01-13.2). CONCLUSIONS Providers varied in accuracy predicting post-arrest outcomes and most errors were optimistic. Self-reported confidence explained little variation in accuracy.
Collapse
Affiliation(s)
- Alexis Steinberg
- University of Pittsburgh, Department of Critical Care Medicine and Neurology, Pittsburgh, PA, USA.
| | - Clifton Callaway
- University of Pittsburgh, Department of Emergency Medicine, Pittsburgh, PA, USA.
| | - Cameron Dezfulian
- University of Pittsburgh, Department of Critical Care Medicine, Pittsburgh, PA, USA.
| | - Jonathan Elmer
- University of Pittsburgh, Department of Critical Care Medicine, Emergency Medicine and Neurology, Pittsburgh, PA, USA.
| |
Collapse
|
52
|
Hosseini M, Wilson RH, Crouzet C, Amirhekmat A, Wei KS, Akbari Y. Resuscitating the Globally Ischemic Brain: TTM and Beyond. Neurotherapeutics 2020; 17:539-562. [PMID: 32367476 PMCID: PMC7283450 DOI: 10.1007/s13311-020-00856-z] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
Cardiac arrest (CA) afflicts ~ 550,000 people each year in the USA. A small fraction of CA sufferers survive with a majority of these survivors emerging in a comatose state. Many CA survivors suffer devastating global brain injury with some remaining indefinitely in a comatose state. The pathogenesis of global brain injury secondary to CA is complex. Mechanisms of CA-induced brain injury include ischemia, hypoxia, cytotoxicity, inflammation, and ultimately, irreversible neuronal damage. Due to this complexity, it is critical for clinicians to have access as early as possible to quantitative metrics for diagnosing injury severity, accurately predicting outcome, and informing patient care. Current recommendations involve using multiple modalities including clinical exam, electrophysiology, brain imaging, and molecular biomarkers. This multi-faceted approach is designed to improve prognostication to avoid "self-fulfilling" prophecy and early withdrawal of life-sustaining treatments. Incorporation of emerging dynamic monitoring tools such as diffuse optical technologies may provide improved diagnosis and early prognostication to better inform treatment. Currently, targeted temperature management (TTM) is the leading treatment, with the number of patients needed to treat being ~ 6 in order to improve outcome for one patient. Future avenues of treatment, which may potentially be combined with TTM, include pharmacotherapy, perfusion/oxygenation targets, and pre/postconditioning. In this review, we provide a bench to bedside approach to delineate the pathophysiology, prognostication methods, current targeted therapies, and future directions of research surrounding hypoxic-ischemic brain injury (HIBI) secondary to CA.
Collapse
Affiliation(s)
- Melika Hosseini
- Department of Neurology, School of Medicine, University of California, Irvine, USA
| | - Robert H Wilson
- Department of Neurology, School of Medicine, University of California, Irvine, USA
- Beckman Laser Institute, University of California, Irvine, USA
| | - Christian Crouzet
- Department of Neurology, School of Medicine, University of California, Irvine, USA
- Beckman Laser Institute, University of California, Irvine, USA
| | - Arya Amirhekmat
- Department of Neurology, School of Medicine, University of California, Irvine, USA
| | - Kevin S Wei
- Department of Neurology, School of Medicine, University of California, Irvine, USA
| | - Yama Akbari
- Department of Neurology, School of Medicine, University of California, Irvine, USA.
- Beckman Laser Institute, University of California, Irvine, USA.
| |
Collapse
|
53
|
Bennis FC, Teeuwen B, Zeiler FA, Elting JW, van der Naalt J, Bonizzi P, Delhaas T, Aries MJ. Improving Prediction of Favourable Outcome After 6 Months in Patients with Severe Traumatic Brain Injury Using Physiological Cerebral Parameters in a Multivariable Logistic Regression Model. Neurocrit Care 2020; 33:542-551. [PMID: 32056131 PMCID: PMC7505885 DOI: 10.1007/s12028-020-00930-6] [Citation(s) in RCA: 32] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Background/Objective Current severe traumatic brain injury (TBI) outcome prediction models calculate the chance of unfavourable outcome after 6 months based on parameters measured at admission. We aimed to improve current models with the addition of continuously measured neuromonitoring data within the first 24 h after intensive care unit neuromonitoring. Methods Forty-five severe TBI patients with intracranial pressure/cerebral perfusion pressure monitoring from two teaching hospitals covering the period May 2012 to January 2019 were analysed. Fourteen high-frequency physiological parameters were selected over multiple time periods after the start of neuromonitoring (0–6 h, 0–12 h, 0–18 h, 0–24 h). Besides systemic physiological parameters and extended Corticosteroid Randomisation after Significant Head Injury (CRASH) score, we added estimates of (dynamic) cerebral volume, cerebral compliance and cerebrovascular pressure reactivity indices to the model. A logistic regression model was trained for each time period on selected parameters to predict outcome after 6 months. The parameters were selected using forward feature selection. Each model was validated by leave-one-out cross-validation. Results A logistic regression model using CRASH as the sole parameter resulted in an area under the curve (AUC) of 0.76. For each time period, an increased AUC was found using up to 5 additional parameters. The highest AUC (0.90) was found for the 0–6 h period using 5 parameters that describe mean arterial blood pressure and physiological cerebral indices. Conclusions Current TBI outcome prediction models can be improved by the addition of neuromonitoring bedside parameters measured continuously within the first 24 h after the start of neuromonitoring. As these factors might be modifiable by treatment during the admission, testing in a larger (multicenter) data set is warranted. Electronic supplementary material The online version of this article (10.1007/s12028-020-00930-6) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Frank C Bennis
- Department of Biomedical Engineering, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands. .,MHeNS School for Mental Health and Neuroscience, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands. .,CARIM School for Cardiovascular Diseases, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands.
| | - Bibi Teeuwen
- Department of Biomedical Engineering, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands
| | - Frederick A Zeiler
- Section of Neurosurgery, Department of Surgery, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.,Department of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.,Biomedical Engineering, Faculty of Engineering, University of Manitoba, Winnipeg, Canada.,Division of Anaesthesia, Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK
| | - Jan Willem Elting
- Department of Clinical Neurophysiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.,Department of Neurology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | - Joukje van der Naalt
- Department of Neurology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | - Pietro Bonizzi
- Department of Data Science and Knowledge Engineering, Maastricht University, Maastricht, The Netherlands
| | - Tammo Delhaas
- Department of Biomedical Engineering, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands.,CARIM School for Cardiovascular Diseases, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands
| | - Marcel J Aries
- MHeNS School for Mental Health and Neuroscience, Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands.,Department of Intensive Care, Maastricht University Medical Center, Maastricht University, Maastricht, The Netherlands
| |
Collapse
|